35 U S C 271 E 2 C Ii Cases

Explore 1 court opinions on 35 U S C 271 E 2 C Ii . AI-powered plain English summaries, key holdings, and legal analysis.

1 recent cases analyzed in this topic area.

Courts Deciding 35 U S C 271 E 2 C Ii Cases

cafc (1)

Recent 35 U S C 271 E 2 C Ii Opinions (1)

Incyte Corporation v. Sun Pharmaceutical Industries, Ltd.

CAFC Affirms Biosimilar Infringement Finding for Ruxolitinib Patents

cafc · 2025-05-07 · Plaintiff Win · Impact: 65/100

Incyte Corporation v. Sun Pharmaceutical Industries, Ltd., decided by Federal Circuit on May 7, 2025, resulted in a plaintiff win outcome. The core dispute centered on whether Sun Pharma's proposed bi...

35 U S C 271 E 2 C Ii by Court

Supreme Court First Circuit Second Circuit Third Circuit Fourth Circuit Fifth Circuit Sixth Circuit Seventh Circuit Eighth Circuit Ninth Circuit Tenth Circuit Eleventh Circuit D.C. Circuit Federal Circuit

35 U S C 271 E 2 C Ii by State

California Texas New York Florida Illinois Pennsylvania Ohio Georgia Michigan New Jersey Virginia Washington Massachusetts North Carolina

Related Resources

35-u-s-c-271-e-2-c-ii- Legal Definition 35-u-s-c-271-e-2-c-ii- Practice Area Guide 35-u-s-c-271-e-2-c-ii- Landmarks Home Search Cases States Courts Topic Rankings